Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 2
1964 1
1968 1
1969 2
1972 1
1976 1
1978 1
1979 1
1980 3
1981 4
1982 3
1983 3
1984 2
1992 1
1993 1
1994 3
1995 6
1996 1
1997 4
1998 2
1999 2
2000 1
2001 3
2002 3
2003 1
2004 6
2005 6
2006 12
2007 8
2008 8
2009 8
2010 3
2011 4
2012 8
2013 6
2014 8
2015 6
2016 12
2017 6
2018 8
2019 9
2020 16
2021 19
2022 19
2023 11

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
Imai M, Ito M, Kiso M, Yamayoshi S, Uraki R, Fukushi S, Watanabe S, Suzuki T, Maeda K, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Halfmann PJ, Kawaoka Y. Imai M, et al. Among authors: fukushi s. N Engl J Med. 2023 Jan 5;388(1):89-91. doi: 10.1056/NEJMc2214302. Epub 2022 Dec 7. N Engl J Med. 2023. PMID: 36476720 Free PMC article. No abstract available.
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.
Takashita E, Yamayoshi S, Simon V, van Bakel H, Sordillo EM, Pekosz A, Fukushi S, Suzuki T, Maeda K, Halfmann P, Sakai-Tagawa Y, Ito M, Watanabe S, Imai M, Hasegawa H, Kawaoka Y. Takashita E, et al. Among authors: fukushi s. N Engl J Med. 2022 Aug 4;387(5):468-470. doi: 10.1056/NEJMc2207519. Epub 2022 Jul 20. N Engl J Med. 2022. PMID: 35857646 Free PMC article. No abstract available.
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.
Uraki R, Halfmann PJ, Iida S, Yamayoshi S, Furusawa Y, Kiso M, Ito M, Iwatsuki-Horimoto K, Mine S, Kuroda M, Maemura T, Sakai-Tagawa Y, Ueki H, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Pekosz A, Kandeil A, Webby RJ, Wang Z, Imai M, Suzuki T, Kawaoka Y. Uraki R, et al. Among authors: fukushi s. Nature. 2022 Dec;612(7940):540-545. doi: 10.1038/s41586-022-05482-7. Epub 2022 Nov 2. Nature. 2022. PMID: 36323336
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways.
Iwata-Yoshikawa N, Kakizaki M, Shiwa-Sudo N, Okura T, Tahara M, Fukushi S, Maeda K, Kawase M, Asanuma H, Tomita Y, Takayama I, Matsuyama S, Shirato K, Suzuki T, Nagata N, Takeda M. Iwata-Yoshikawa N, et al. Among authors: fukushi s. Nat Commun. 2022 Oct 15;13(1):6100. doi: 10.1038/s41467-022-33911-8. Nat Commun. 2022. PMID: 36243815 Free PMC article.
[Arenavirus infections].
Tani H, Fukushi S, Yoshikawa T, Saijo M, Morikawa S. Tani H, et al. Among authors: fukushi s. Uirusu. 2012;62(2):229-38. doi: 10.2222/jsv.62.229. Uirusu. 2012. PMID: 24153233 Free article. Review. Japanese.
Varicella Vaccine-Induced Infantile Zoster-Like Skin Rash.
Sugai T, Fujita Y, Yamada S, Fukushi S, Inamura E, Hatakeyama K, Shimizu S. Sugai T, et al. Among authors: fukushi s. J Pediatr. 2022 Dec;251:218-219. doi: 10.1016/j.jpeds.2022.08.032. Epub 2022 Aug 23. J Pediatr. 2022. PMID: 36027973 No abstract available.
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.
Uraki R, Iida S, Halfmann PJ, Yamayoshi S, Hirata Y, Iwatsuki-Horimoto K, Kiso M, Ito M, Furusawa Y, Ueki H, Sakai-Tagawa Y, Kuroda M, Maemura T, Kim T, Mine S, Iwamoto N, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Wang Z, Ohmagari N, Theiler J, Fischer W, Korber B, Imai M, Suzuki T, Kawaoka Y. Uraki R, et al. Among authors: fukushi s. Nat Commun. 2023 Mar 23;14(1):1620. doi: 10.1038/s41467-023-37059-x. Nat Commun. 2023. PMID: 36959194 Free PMC article.
Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
Imai M, Halfmann PJ, Yamayoshi S, Iwatsuki-Horimoto K, Chiba S, Watanabe T, Nakajima N, Ito M, Kuroda M, Kiso M, Maemura T, Takahashi K, Loeber S, Hatta M, Koga M, Nagai H, Yamamoto S, Saito M, Adachi E, Akasaka O, Nakamura M, Nakachi I, Ogura T, Baba R, Fujita K, Ochi J, Mitamura K, Kato H, Nakajima H, Yagi K, Hattori SI, Maeda K, Suzuki T, Miyazato Y, Valdez R, Gherasim C, Furusawa Y, Okuda M, Ujie M, Lopes TJS, Yasuhara A, Ueki H, Sakai-Tagawa Y, Eisfeld AJ, Baczenas JJ, Baker DA, O'Connor SL, O'Connor DH, Fukushi S, Fujimoto T, Kuroda Y, Gordon A, Maeda K, Ohmagari N, Sugaya N, Yotsuyanagi H, Mitsuya H, Suzuki T, Kawaoka Y. Imai M, et al. Among authors: fukushi s. Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):e2106535118. doi: 10.1073/pnas.2106535118. Proc Natl Acad Sci U S A. 2021. PMID: 34140350 Free PMC article.
Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.
Takashita E, Yamayoshi S, Fukushi S, Suzuki T, Maeda K, Sakai-Tagawa Y, Ito M, Uraki R, Halfmann P, Watanabe S, Takeda M, Hasegawa H, Imai M, Kawaoka Y. Takashita E, et al. Among authors: fukushi s. N Engl J Med. 2022 Sep 29;387(13):1236-1238. doi: 10.1056/NEJMc2209952. Epub 2022 Sep 7. N Engl J Med. 2022. PMID: 36121928 Free PMC article. No abstract available.
219 results